The overexpression of BCMA and its ligands in MM activates both the classical and alternative nuclear factor kappa B (NFκB)-signaling pathways, which result in increased gene expression for growth, survival, adhesion, angiogenesis, metastasis, osteoclast activation, and immunosuppression [4,14]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.